Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TetraLens for pain management after PRK
NCT06085352Phase 1Completed
- Sponsor
- Vance Thompson Vision
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tetracaine (2 arms), sponsored by Vance Thompson Vision. Primary endpoints: Efficacy of TetraLens BCL in the management of pain following surgical procedures at 6 days and Safety of TetraLens BCL at 6 days. Started Jun 2023; status: completed.
02
Drugs
tetracaine
Beyond the preview
Go deeper on NCT06085352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06085352.